Field Evaluation of a Dual Rapid Immunodiagnostic Test for HIV and Syphilis Infection in Peru

Autor: Juan A Flores, Lourdes B. Ramos, Kelika A. Konda, Emily Huang, Carlos F. Caceres, Silver K. Vargas, Jeffrey D. Klausner, Segundo R. Leon, Claire C. Bristow
Rok vydání: 2016
Předmět:
Male
Treponema pallidum/immunology
Syphilis/diagnosis
Human immunodeficiency virus (HIV)
HIV Infections
HIV Antibodies
medicine.disease_cause
Immunoenzyme Techniques
0302 clinical medicine
Peru
030212 general & internal medicine
Young adult
Treponema
medicine.diagnostic_test
biology
purl.org/pe-repo/ocde/ford#3.02.15 [https]
Antibodies
Bacterial

Test (assessment)
HIV Infections/diagnosis
Infectious Diseases
Female
Antibody
0305 other medical science
Adult
Microbiology (medical)
medicine.medical_specialty
Adolescent
Point-of-Care Systems
Dermatology
Sensitivity and Specificity
Transgender Persons
Article
Young Adult
03 medical and health sciences
Internal medicine
Confidence Intervals
medicine
Humans
Syphilis
Treponema pallidum
Homosexuality
Male

Antibodies
Bacterial/immunology

Sex Workers
030505 public health
business.industry
Public Health
Environmental and Occupational Health

medicine.disease
biology.organism_classification
Confidence interval
Immunoassay
Immunology
biology.protein
HIV Antibodies/immunology
Reagent Kits
Diagnostic

business
Peru/epidemiology
Zdroj: Sexually Transmitted Diseases. 43:57-60
ISSN: 0148-5717
DOI: 10.1097/olq.0000000000000387
Popis: BACKGROUND: Integrated prevention for HIV and syphilis is warranted because both syphilis and HIV infections have evidence-based, scalable interventions using current health care mechanisms. The advent of dual rapid point-of-care tests, single devices that can detect multiple infections using the same specimen, provides the opportunity to integrate the screening of syphilis into HIV prevention programs, potentially increasing the numbers of people tested and allowing for same-day testing and treatment. The aim of our study was to evaluate the MedMira Multiplo Rapid TP/HIV Antibody Test (MedMira Inc, Halifax, Nova Scotia, Canada), a qualitative, rapid immunoassay that detects antibodies to Treponema pallidum and HIV. METHODS: The reference test for comparison to the T. pallidum component of the Multiplo TP/HIV Test was the T. pallidum particle agglutination assay. For the HIV component, the reference test included a fourth-generation enzyme immunoassay with a confirmatory Western blot test. RESULTS: The sensitivity and specificity for the HIV antibody component were 93.8% (95% confidence interval [CI], 69.8%-99.8%) and 100% (95% CI, 97.7%-100%), respectively. The T. pallidum component of the test had a sensitivity of 81.0% (95% CI, 68.1%-94.6%) and a specificity of 100% (95% CI, 97.6%-100%). CONCLUSIONS: Our study showed excellent performance of the HIV antibody component of the test and very good performance for the T. pallidum antibody component of the MedMira Multiplo Rapid TP/HIV Antibody Test, which should be considered to improve screening coverage. Use of effective dual tests will create improved access to more comprehensive care by integrating the screening of syphilis into HIV prevention programs.
Databáze: OpenAIRE